Introduction

Gram-negative bacillary meningitis (GNBM) is commonly seen in infants and
Discussion
Meningitis caused by Gram-negative enteric bacteria is rare in adults but can be found most often after disruption of the dura-arachnoid barrier secondary to trauma or neurosurgery. 1 It may also occur spontaneously in patients who are elderly, immunocompromised, or chronically debilitated. 3 It occasionally spreads directly from an adjacent focus of infection as in the case of mastoiditis or sinusitis. 4 The most common organisms involved are Klebsiella sp, 6 In vivo resistance during therapy can occur, 7 and antagonism when used in combination with gentamicin or cefotaxime has been reported. 8, 9 Aminoglycosides, which have been frequently used, are associated with low systemic therapeutic-toxic ratio, diminished effectiveness in actively infected CSF, and difficulty in obtaining bactericidal levels in the CSF. 10 The third generation cephalosporins, including moxalactam, ceftriaxone, cefotaxime, and ceftazidime are effective against GNBM [11] [12] [13] [14] and enter the CSF in high bactericidal concentrations. 14 28 We agree with previous reports that in a select group of patients with GNBM with multiple-drug resistance and in vitro susceptibility to TMP-SMX and aminoglycosides, this combination should be considered as a viable and potentially successful treatment option.
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